(Q43856089)

English

High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1.

scientific article published on 11 July 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1. (English)

1 reference

Europe PubMed Central

27 November 2017

1 reference

based on heuristic

inferred from title

7

object named as

Olle Stål

1 reference

Europe PubMed Central

27 November 2017

author name string

Elin Karlsson

1

1 reference

Europe PubMed Central

27 November 2017

Marie Ahnström Waltersson

2

1 reference

Europe PubMed Central

27 November 2017

Josefine Bostner

3

1 reference

Europe PubMed Central

27 November 2017

Gizeh Pérez-Tenorio

4

1 reference

Europe PubMed Central

27 November 2017

Birgit Olsson

5

1 reference

Europe PubMed Central

27 November 2017

Anna-Lotta Hallbeck

6

1 reference

Europe PubMed Central

27 November 2017

publication date

11 July 2011

1 reference

Europe PubMed Central

27 November 2017

Genes, Chromosomes and Cancer

1 reference

Europe PubMed Central

27 November 2017

50

1 reference

Europe PubMed Central

27 November 2017

10

1 reference

Europe PubMed Central

27 November 2017

775-787

1 reference

Europe PubMed Central

27 November 2017

Role of cyclin D1 in ErbB2-positive breast cancer and tamoxifen resistance

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

MYC activity mitigates response to rapamycin in prostate cancer through 4EBP1-mediated inhibition of autophagy

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Detailed map of a region commonly amplified at 11q13-->q14 in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

A role for the scaffolding adapter GAB2 in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Focal amplification and oncogene dependency of GAB2 in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Estrogen receptor-alpha phosphorylation at serine 305, nuclear p21-activated kinase 1 expression, and response to tamoxifen in postmenopausal breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

The docking protein Gab2 is overexpressed and estrogen regulated in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Minireview: Cyclin D1: normal and abnormal functions

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Molecular cloning and characterization of a novel p70 S6 kinase, p70 S6 kinase beta containing a proline-rich region

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Amplification of HSD17B1 and ERBB2 in primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Novel patterns of genome rearrangement and their association with survival in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Patterns of dna amplification at band q13 of chromosome 11 in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Cyclin D1, EMS1 and 11q13 amplification in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Amplification of the BRCA2 Pathway Gene EMSY in Sporadic Breast Cancer Is Related to Negative Outcome

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Cloning and characterization of p70(S6K beta) defines a novel family of p70 S6 kinases

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes--a review

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

S6 kinase 2 promotes breast cancer cell survival via Akt.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Activation of mammalian target of rapamycin (mTOR) by insulin is associated with stimulation of 4EBP1 binding to dimeric mTOR complex 1

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Cytosol estradiol receptor in human mammary carcinoma: An assay based on isoelectric focusing in polyacrylamide gel

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

21 January 2018

Prognostic relevance of gene amplifications and coamplifications in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

7 January 2021

based on heuristic

inferred from DOI database lookup

Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

7 January 2021

based on heuristic

inferred from DOI database lookup

Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

7 January 2021

based on heuristic

inferred from DOI database lookup

Deletion mapping of chromosome segment 11q24-q25, exhibiting extensive allelic loss in early onset breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

7 January 2021

based on heuristic

inferred from DOI database lookup

EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromosome 11q22.3-q25 LOH in ovarian cancer: association with a more aggressive disease course and involved subregions

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

7 January 2021

based on heuristic

inferred from DOI database lookup

A consistent pattern ofRIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous analysis of c-erbB-2 expression and DNA content in breast cancer using flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20900

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/GCC.20900

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43856089&oldid=2103925284"